KAI Chooses OpenClinica Enterprise for Phase I –IV Clinical Trials

Share Article

Commercial open source EDC software provides optimal level of freedom and control for regulated clinical trials

KAI chooses OpenClinica clinical trial software
OpenClinica’s powerful technology and flexible model enable us to deploy a cutting edge EDC that meets the needs of both our industry and government clients.

OpenClinica, LLC is pleased to announce that Rockville, MD-based KAI Research, Inc., (KAI), an Altarum Company, has selected the OpenClinica Enterprise Edition to power Phase I – IV clinical trials. Founded in 1986, KAI is a full service contract research organization (CRO) that provides innovative, cost-effective, and practical support to pharmaceutical, biotech and academic institutions, and the National Institutes of Health (NIH).

The OpenClinica software enhances clinical trials by streamlining electronic data capture (EDC) and clinical data management. The result is higher quality and faster access to the data.

“KAI is a CRO that relies on cutting edge information technology to help deliver the greatest value to our clients,” states Patti Shugarts, chief operating officer at KAI. She continues: “OpenClinica’s powerful technology and flexible model enable us to deploy a cutting edge EDC that meets the needs of both our industry and government clients.”

The OpenClinica clinical trial software is provided under a commercial open source model, and available in two editions. The OpenClinica Community Edition software is freely available under a widely accepted open source license. The OpenClinica Enterprise Edition consists of a fully validated version of the open source technology with additional capabilities, services, and resource ideal for mission critical research and highly regulated environments. The OpenClinica software is currently in use at over 500 biopharma sponsors, CROs, academic centers, and government agencies worldwide.

KAI Research Media Contact:
Patti Shugarts
pshugarts(at)kai-research(dot)com

OpenClinica Media Contact:
Ben Baumann
bbaumann(at)openclinica(dot)com

KAI Research, Inc.

KAI Research Inc., (KAI) a wholly owned for-profit subsidiary of the Altarum Institute, has focused on providing innovative, cost-effective, and practical support to the pharmaceutical, biotech and academic institutions, Department of Defense and the National Institutes of Health (NIH). For more information on KAI services visit http://www.kai-research.com and follow @KAIResearch on Twitter.

About OpenClinica®

OpenClinica enhances the productivity of clinical trials through commercial open source software. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information – including product downloads – visit http://www.openclinica.com or follow @OpenClinica on Twitter.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ben Baumann
Follow us on

Media

OpenClinica clinical trial software